Related Experiment Video
Updated: May 11, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Oral Kaposi's sarcoma: a review and update
Mahnaz Fatahzadeh1, Robert A Schwartz
1Oral Medicine, New Jersey Dental School, Newark, NJ 07103-2714, USA. fatahza@umdnj.edu
Kaposi's sarcoma (KS) in the mouth, or oral KS (OKS), is linked to HIV infection and can mimic other conditions. Management varies, with prevention strategies focusing on HHV-8 screening and early sirolimus use in transplant patients.
Area of Science:
- Oncology
- Infectious Diseases
- Dermatology
Background:
- Kaposi's sarcoma (KS) is a neoplasm with four types, frequently involving the oral cavity, especially in AIDS-KS cases.
- Oral KS (OKS) can indicate undiagnosed HIV infection and is associated with disseminated disease, impacting diagnosis and treatment.
- OKS presents as plaques or tumors on the palate, gingiva, or tongue, ranging from asymptomatic to interfering with mastication.
Purpose of the Study:
- To review the clinicopathologic features, diagnostic challenges, and management of oral Kaposi's sarcoma (OKS).
- To highlight the association of OKS with HIV infection and its implications.
- To discuss strategies for preventing post-transplant OKS.
Main Methods:
- Clinical and pathological review of oral Kaposi's sarcoma cases.
- Differential diagnosis considerations for OKS.
- Discussion of current and proposed management and prevention strategies.
Main Results:
- OKS is most common in AIDS-KS and can signal HIV infection.
- Clinical differentiation from other oral lesions is crucial.
- Management ranges from observation to chemotherapy, with immunosuppression modification posing risks.
Conclusions:
- OKS requires careful clinical distinction from other oral pathologies.
- Management strategies must consider KS type, staging, and patient factors.
- Preventive measures for post-transplant OKS include HHV-8 screening and early sirolimus use.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Endocarditis II: Clinical Features of Infective Endocarditis

